| RS1655391926 |
SEMA4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1655397950 |
KDM5B
|
Health Risk |
Pathogenic |
— |
| RS1655517675 |
FMO3
|
Health Risk |
Pathogenic |
— |
| RS1655521504 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1655612629 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS1655690067 |
KDM5B
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1655719165 |
CACNA1E
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1655731489 |
FMO3
|
Health Risk |
Pathogenic |
— |
| RS1655736013 |
FMO3
|
Health Risk |
Likely pathogenic |
Trimethylaminuria, Trimethylaminuria |
| RS1655753199 |
CACNA1E
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1655775567 |
SZT2
|
Health Risk |
Likely pathogenic |
— |
| RS1655824699 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS1655825221 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS1655828678 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS1655833195 |
COL11A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1655878450 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS1655881883 |
ASH1L
|
Health Risk |
Pathogenic |
— |
| RS1655882215 |
FMO3
|
Health Risk |
Pathogenic |
— |
| RS1655927823 |
SZT2
|
Health Risk |
Pathogenic |
— |
| RS1655966037 |
CD46
|
Health Risk |
Pathogenic |
— |
| RS1656161931 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS1656163649 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1656200306 |
FMO3
|
Health Risk |
Pathogenic |
Trimethylaminuria, Trimethylaminuria |
| RS1656251554 |
GLMN
|
Health Risk |
Likely pathogenic |
Glomuvenous malformation, Glomuvenous malformation |
| RS1656295216 |
PIGK
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures |
| RS1656300594 |
KDM5B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1656338337 |
CACNA1E
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1656391998 |
PIGK
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures |
| RS1656392054 |
PIGK
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures |
| RS1656408131 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1656416727 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1656419435 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Usher syndrome type 2 |
| RS1656506214 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS1656591590 |
EGLN1
|
Health Risk |
Pathogenic |
Erythrocytosis, familial |
| RS1656640356 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1656646221 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 39 |
| RS1656646424 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1656647155 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1656706610 |
TGFB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS1656796807 |
ASPM
|
Health Risk |
Likely pathogenic |
Microcephaly 5, primary |
| RS1656826074 |
NOS1AP
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 22 |
| RS1656851989 |
PRG4
|
Health Risk |
Conflicting classifications of pathogenicity |
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, Camptodactyly-arthropathy-coxa vara-pericarditis syndrome |
| RS1656892077 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1656901821 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinal dystrophy |
| RS1656936749 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1656938047 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1656942613 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Monogenic hearing loss |
| RS1656943603 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1656944247 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1656958874 |
CD46
|
Health Risk |
Likely pathogenic |
— |
| RS1657010162 |
CHIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Chitotriosidase deficiency, Chitotriosidase deficiency |
| RS1657029417 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1657036615 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinal dystrophy |
| RS1657042446 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS1657198788 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS1657235121 |
PRG4
|
Health Risk |
Likely pathogenic |
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, Camptodactyly-arthropathy-coxa vara-pericarditis syndrome |
| RS1657248003 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS1657341426 |
ASPM
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephaly 5, primary |
| RS1657345576 |
EDARADD
|
Health Risk |
Pathogenic |
Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type |
| RS1657367896 |
ASPM
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 5, primary |
| RS1657371141 |
PRG4
|
Health Risk |
Likely pathogenic |
— |
| RS1657377652 |
PRG4
|
Health Risk |
Pathogenic |
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, Camptodactyly-arthropathy-coxa vara-pericarditis syndrome |
| RS1657525413 |
CENPF
|
Health Risk |
Likely pathogenic |
Cystinuria, Cystinuria |
| RS1657533128 |
POGZ
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1657541606 |
POGZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Intellectual disability |
| RS1657564568 |
PIGO
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS1657568800 |
IARS2
|
Health Risk |
Pathogenic |
— |
| RS1657570765 |
POMGNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Congenital Muscular Dystrophy |
| RS1657694750 |
SERPINC1
|
Health Risk |
Pathogenic |
Hereditary antithrombin deficiency, Hereditary antithrombin deficiency |
| RS1657717722 |
FLAD1
|
Health Risk |
Likely pathogenic |
— |
| RS1657723514 |
FLAD1
|
Health Risk |
Pathogenic |
Myopathy with abnormal lipid metabolism, Myopathy with abnormal lipid metabolism |
| RS1657737496 |
OPTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary open angle glaucoma, Amyotrophic lateral sclerosis type 12 |
| RS1657743081 |
SERPINC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary antithrombin deficiency, Hereditary antithrombin deficiency |
| RS1657782821 |
CENPF
|
Health Risk |
Likely pathogenic |
Stromme syndrome, Stromme syndrome |
| RS1657796004 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1657798642 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 39 |
| RS1657799383 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2, Usher syndrome type 2 |
| RS1657799720 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1657800056 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1657805631 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1657805957 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1657810994 |
FLAD1
|
Health Risk |
Pathogenic |
— |
| RS1657824312 |
POMGNT1
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS1657829644 |
POMGNT1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1657837348 |
PEX19
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 12A (Zellweger), Peroxisome biogenesis disorder 12A (Zellweger) |
| RS1657858393 |
PEX11B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1657864516 |
POMGNT1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 |
| RS1657873534 |
PEX19
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 12A (Zellweger), Peroxisome biogenesis disorder |
| RS1657877888 |
RAB3GAP2
|
Health Risk |
Likely pathogenic |
Martsolf syndrome, Martsolf syndrome |
| RS1657881990 |
AMPD1
|
Health Risk |
Likely pathogenic |
Muscle AMP deaminase deficiency, Muscle AMP deaminase deficiency |
| RS1657900739 |
POMGNT1
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS1657901999 |
H3-3A
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Bryant-Li-Bhoj neurodevelopmental syndrome 1 |
| RS1657903750 |
H3-3A
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, H3-3A-related disorder |
| RS1657904113 |
H3-3A
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Bryant-Li-Bhoj neurodevelopmental syndrome 1 |
| RS1657908048 |
SERPINC1
|
Health Risk |
Likely pathogenic |
Hereditary antithrombin deficiency, Hereditary antithrombin deficiency |
| RS1657909645 |
SERPINC1
|
Health Risk |
Pathogenic |
Hereditary antithrombin deficiency, Hereditary antithrombin deficiency |
| RS1657911759 |
USH2A
|
Health Risk |
Pathogenic |
Ear malformation, Ear malformation |
| RS1657913203 |
SERPINC1
|
Health Risk |
Likely pathogenic |
Hereditary antithrombin deficiency, Hereditary antithrombin deficiency |
| RS1657920193 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS1657921221 |
USH2A
|
Health Risk |
Pathogenic |
— |